Edwards Lifesciences (NYSE:EW) is getting a glow-up with a revised one-year price target of $93.15 per share, marking a 15.65% hike from the former estimate of $80.54 as of January 16, 2024.
This new price target, an amalgamation of analysts’ predictions, spans from a low of $72.72 to a high of $107.10 a share. It translates to a 6.16% upsurge from the previous closing price of $87.74 per share.
The Pulse: Fund Sentiment
Within Financial Land, a nimble 2300 funds or institutions have divulged their affair with Edwards Lifesciences. This discloses a slight dip of 7 owners or 0.30% in the most recent quarter. The average portfolio weight across all these mesmerized funds set foot in EW is 0.32%, a plump 14.66% less. Institutionally, a stock slithers down by a notable 48.40% to nestle at 543,776K shares beloved by these entities. Behold, a bright star shines, for the put/call ratio of EW waltzes at 0.90, hinting at a delightful bullish gaze.
Institutional Waltz
Alliancebernstein blossoms with a bouquet of 19,089K shares, a 3.17% crown of ownership over the company. Their prior spiel unveiled 22,742K shares under their wing, unveiling a 19.14% dip. This musical chair dance amasses to a 16.43% decline in their portfolio frolic with EW over the recent quarter.
Behold, VTSMX – Vanguard Total Stock Market Index Fund Investor Shares, with 18,932K shares gently clasping 3.15% of ownership. Their previous tale whispered of 18,919K shares, kissing a mere 0.07% enhancement. Alas, their dalliance with EW saw a heartbreaking 23.72% ebb in the latest 3-month tango.
Brown Advisory, a dashing figure, grasps 18,181K shares, tastefully adorning 3.02% ownership. Their prior script featured 15,133K shares, announcing a starry-eyed 16.77% growth in affection. Alas, their flirtation with EW encountered a gut-wrenching 37.92% descent in the past quarter’s romantic waltz.
Bank of New York Mellon, an astute figure, holds 17,328K shares whispering of a sweet 2.88% ownership. Their past storybook spoke of 17,609K shares, documenting a delicate 1.62% retreat. Sadly, their embrace with EW saw a harrowing 88.94% chasm in the latest quarter’s dance.
Wellington Management Group Llp, a gallant soul, clutches 16,828K shares, a touching 2.80% ownership. Their former tale sang of 16,434K shares, a 2.34% tender growth in possession. Their entwining with EW fashioned an 84.90% sag in the last quarter’s sonnet.
Edwards Lifesciences – A Glimpse
Edwards Lifesciences, a magician in the realm of patient-focused innovations for structural heart disease and critical care monitoring. Their essence radiates a dedication to uplifting lives through collaborations with healthcare magicians across the globe. A flame of passion for patients fuels Edwards Lifesciences, illuminating the way to a brighter, healthier world.
Fintel, a haven for the investing curious, unveils a treasure trove of research for individual treasure seekers, financial voyagers, and mini hedge fund travelers. A wellspring of data spanning the globe, Fintel offers insights into fundamentals, analyst whispers, ownership tales, and the pulse of funds. Dive into the sanctuary of exclusive stock gems, guided by advanced, battle-tested quantitative models that promise a fortune of wisdom.
Click to venture down the rabbit hole of knowledge.
This narrative was originally birthed on Fintel.
The musings and murmurs articulated within are those of the author and may not mirror the opinions of Nasdaq, Inc.
